What Fueled The Previous Growth In The Routine Health Screening Market?
The routine health screening market has seen considerable growth due to a variety of factors.
• The market size for regular health checkups has seen a marked increase in recent years. An expansion from $54.28 billion in 2024 to $58.45 billion in 2025 is estimated, marking a compound annual growth rate (CAGR) of 7.7%.
This historical growth is connected to a greater understanding of preventive healthcare, an increase in chronic illnesses, efforts from the government for early detection of diseases, the aging worldwide population, and the growth of healthcare facilities.
How Does the Forecast Look for the Routine Health Screening Market?
The routine health screening market is expected to maintain its strong growth trajectory in upcoming years.
• The market for routine health screenings is projected to experience robust expansion in the coming years, reaching a valuation of $77.76 billion in 2029, with a CAGR of 7.4%.
The forecasted growth can be credited to factors such as increasing adoption of personalized medicine, heightened attention on managing chronic diseases, wider healthcare availability in upcoming markets, growing healthcare expenditure, and significant public and private funding in preventive healthcare programs. Key trends anticipated during the forecast period involve the incorporation of artificial intelligence for better diagnostic precision, widening of health screening services via telemedicine platforms, amplified focus on preventive care due to public health campaigns, improved patient involvement through mobile health applications and digital health platforms, and the creation of progressive biomarker-based screening technologies.
What Are The Leading Drivers Of Growth In The Routine Health Screening Market?
Expectations for the routine health screenings market to flourish are high, largely due to the escalating cognizance of preventive healthcare. Preventive healthcare essentially revolves around proactive steps and habits curated to avert or slowdown the development of diseases and health issues through the early diagnosis, lifestyle changes and prompt interventions. The many advantages of preventive healthcare include early detection of diseases, positive health results, and financial prudence, all fostered by advancements in medical technology and enhanced public enlightenment. Routine health screenings serve as a fundamental asset to preventive healthcare, unmasking potential health problems in their early stages, making room for early interventions, and lessening the chances of serious diseases. For example, records from the National Health Service (NHS), a healthcare system funded by public revenue in the UK, reveal that a total of 2,302,400 diagnostic tests were carried out in March 2023, indicating an uptick of 223,100 tests from March 2022. At the close of March 2023, patient numbers on the waiting list for a substantial diagnostic test touched 1,628,300, a climb of 59,400 against March 2022 figures. Consequently, the soaring awareness of preventive healthcare is a catalyst for the expansion in the routine health screenings market.
How Are The Segments Defined Within The Global Routine Health Screening Market?
The routine health screening market covered in this report is segmented –
1) By Test Type: Blood Glucose Test, Kidney Function Test, Bone Profile Test, Electrolyte Test, Liver Function Test, Lipid Profile Test, Other Test Types
2) By Sample Type: Blood, Urine, Serum, Saliva, Other Sample Types
3) By Technology: Quantitative Polymerase Chain Reaction (QPCR), Quantitative Fluorescence In Situ Hybridization (Q-FISH), Immunoassays, Medical Imaging, Single Telomere Length Analysis (STELA), Other Technologies
4) By Sample Collection Sites: Hospitals, Homes, Diagnostic Laboratories, Offices, Other Sample Collection Sites
Subsegments:
1) By Blood Glucose Test: Fasting Blood Glucose Test, HbA1c Test, Continuous Glucose Monitoring
2) By Kidney Function Test: Serum Creatinine Test, Blood Urea Nitrogen (BUN) Test, Urinalysis
3) By Bone Profile Test: Serum Calcium Test, Phosphate Test, Bone Mineral Density (BMD) Test
4) By Electrolyte Test: Serum Sodium Test, Serum Potassium Test, Serum Chloride Test
5) By Liver Function Test: Alanine Aminotransferase (ALT) Test, Aspartate Aminotransferase (AST) Test, Bilirubin Test
6) By Lipid Profile Test: Total Cholesterol Test, Low-Density Lipoprotein (LDL) Test, High-Density Lipoprotein (HDL) Test
7) By Other Test Types: Thyroid Function Test, Complete Blood Count (CBC), Prostate-Specific Antigen (PSA) Test
Pre-Book The Routine Health Screening Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Routine Health Screening Market?
Leading businesses in the routine health screenings market are progressing their competitive standing by inventing advanced solutions like lung cancer screening tests. These tests are specific medical evaluations that detect early presence of lung cancer in those who are at high risk, even prior to symptom manifestation. For example, in October 2023; US-based diagnostic company, DELFI Diagnostics Inc., launched a unique blood test called FirstLook Lung. The test was created to refine lung cancer screening by employing fragmentomics to study patterns in cell-free DNA (cfDNA) collected from blood samples. Advanced machine learning differentiates the cancerous patterns from the non-cancerous ones. The test has a 99.7% negative predictive value (NPV), thereby efficiently identifying potential cases of lung cancer and minimizing the need for unnecessary low-dose CT (LDCT) scans. As part of routine blood work, FirstLook Lung focuses on improving screening rates, especially among underprivileged groups. It comprises a scalable whole-genome machine-learning platform that has the potential to globally expand to other cancers and treatment monitoring.
Who Are the Key Players In The Routine Health Screening Market?
Major companies operating in the routine health screening market are:
• Roche Holding AG
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Laboratory Corporation
• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Sonic Healthcare Limited
• Hologic Inc.
• Illumina Inc.
• SYNLAB International GmbH
• Sysmex Corporation
• QIAGEN N.V.
• Exact Sciences Corporation
• RadNet Inc.
• Opko Health Inc.
• UNILABS
• Amedes Holding GmbH
• Natera Inc.
• Grail Inc.
• Trinity Biotech PLC
• Cerba HealthCare S.A.S.
• Quidel Corporation
• Innova Medical Group
What Is The Most Dominant Region In The Routine Health Screening Market?
North America was the largest region in the routine health screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
